T. Aas

T. Aas, J. Nordenström, M. Hellström, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer

T. Aas, R. Skjærven, K. Collett, 1996 .

Letrozole is Superior to Anastrozole in Suppressing Breast Cancer Tissue and Plasma Estrogen Levels

T. Aas, P. Lønning, J. Geisler, 2008, Clinical Cancer Research.

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

T. Aas, S. Geisler, P. Lønning, 2022, Genome medicine.

Diet in women with breast cancer compared to healthy controls - What is the difference?

T. Aas, J. T. Kvaløy, H. Søiland, 2018, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

T. Aas, P. Lønning, S. Knappskog, 2014, Acta oncologica.

Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation

T. Aas, J. Nordenström, M. Hellström, 2022, Annals of Internal Medicine.

Breast cancer aromatase expression evaluated by the novel antibody 677: Correlations to intra-tumor estrogen levels and hormone receptor status

T. Aas, P. Lønning, J. Geisler, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway

T. Aas, L. Akslen, E. Schlichting, 2019, European Thyroid Journal.

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

T. Aas, S. Geisler, P. Lønning, 2022, Genome medicine.

Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH‐Study)

Morten Wang Fagerland, T. Aas, J. Nordenström, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer

T. Sørlie, T. Aas, S. Geisler, 2011, British Journal of Cancer.

Impact of EMG Changes in Continuous Vagal Nerve Monitoring in High-Risk Endocrine Neck Surgery

T. Aas, M. Biermann, M. Brauckhoff, 2015, World Journal of Surgery.

Gene Mutations Predict the Response to Neoadjuvant Treatment with 5-Fluorouracil and Mitomycin in Locally Advanced Breast Cancer

T. Aas, S. Geisler, H. Johnsen, 2003 .

Neurogenesis and angiogenesis are associated features of aggressive breast cancer

T. Aas, L. Akslen, Dimitrios Kleftogiannis, 2022, bioRxiv.

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.

Johan Eide, T. Aas, L. Akslen, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counselling: the DNA-BONus study

T. Aas, V. Steen, P. Knappskog, 2015, European Journal of Human Genetics.

Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer

T. Aas, K. Heimdal, P. Møller, 1998 .

Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo

T. Aas, S. Geisler, P. Lønning, 2015, Molecular oncology.

EMG changes during continuous intraoperative neuromonitoring with sustained recurrent laryngeal nerve traction in a porcine model

T. Aas, M. Biermann, P. Husby, 2016, Langenbeck's Archives of Surgery.

Latencies longer than 3.5 ms after vagus nerve stimulation does not exclude a nonrecurrent inferior laryngeal nerve

T. Aas, M. Biermann, M. Brauckhoff, 2014, BMC Surgery.

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy.

T. Aas, S. Geisler, T. Thorsen, 2003, European journal of cancer.

Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups

T. Aas, W. Foulkes, L. Akslen, 2020, Scientific Reports.

Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.

T. Aas, S. Geisler, P. Lønning, 1997, British Journal of Cancer.

Progesterone binding cyst protein in hormone receptor positive breast cancer; a predictive factor for effect of adjuvant tamoxifen treatment.

T. Aas, J. Søreide, A. Skarstein, 1994, Anticancer research.

Angiogenesis does not predict clinical response to doxorubicin monotherapy in patients with locally advanced breast cancer

T. Aas, P. Lønning, L. Akslen, 1997, International journal of cancer.

DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response

T. Aas, S. Geisler, P. Lønning, 2010, Molecular Cancer.

Primary systemic treatment with weekly doxorubicin monotherapy in women with locally advanced breast cancer; clinical experience and parameters predicting outcome.

T. Aas, S. Geisler, P. Lønning, 1996, Acta oncologica.

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

I. Jonassen, T. Aas, J. Bergh, 2017, Scientific Reports.

Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.

T. Aas, L. Akslen, I. Stefansson, 2013, Breast.

Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival

T. Aas, L. Akslen, T. Klingen, 2016, Journal of Clinical Pathology.

Abstract 2651: Nestin expression in tumor cells is associated with the basal-like phenotype and aggressive features in breast cancer.

T. Aas, L. Akslen, K. Collett, 2013 .

Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.

T. Aas, L. Akslen, S. Hofvind, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Positive Effect of Parathyroidectomy Compared to Observation on BMD in a Randomized Controlled Trial of Mild Primary Hyperparathyroidism

T. Aas, J. Nordenström, M. Hellström, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Neoadjuvant olaparib monotherapy in primary triple negative breast cancer

T. Aas, P. Lønning, S. Lundgren, 2019, Annals of Oncology.

Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer

T. Aas, L. Akslen, T. Klingen, 2016, PloS one.

Prognostic and predictive value of changes in tumour cell proliferation in locally advanced breast cancer primarily treated with doxorubicin.

T. Aas, S. Geisler, P. Lønning, 2005, Oncology reports.

Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study.

T. Aas, J. T. Kvaløy, H. Søiland, 2019, Breast.

Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

T. Aas, S. Geisler, P. Lønning, 2001, British Journal of Cancer.

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls.

H. Eriksen, T. Aas, H. Søiland, 2016, Breast.